Avrobio to Initiate Phase 2 Trial with Gene Therapy AVRO-RD-01-201


Gene Therapy – a phase II study is recruiting in Perth and Melbourne


You may have seen in the news (Channel Seven Perth) something about Gene Therapy in Fabry patients? To watch the Channel Seven Perth story video Press Here The company conducting the trial is AVROBIO. Their new study is assessing the efficacy and safety of a new gene therapy treatment AVR-RD-01.


Stem cells are special cells from the blood that can mature into many different cell types. In this study, these cells are collected from the patient, genetically modified and then returned to the patient by Intravenous (IV) infusion. The modified cells may then secrete the missing Alpha-galactosidase A (AGA) enzyme, removing the need for enzyme replacement therapy (ERT). To read about the new clinical trial Press Here


Further details can be discussed with your Fabry Clinic

0 views

+61 (0)412 462 732

Fabry Australia Inc.  |  ABN 70 053 079 595  | Registered Number A0029817E
Terms & Conditions